Not getting sleepy? Study explains why hypnosis doesn't work for all

October 3, 2012 in Neuroscience

Not everyone is able to be hypnotized, and new research from the Stanford University School of Medicine shows how the brains of such people differ from those who can easily be.

The study, published in the October issue of , uses data from functional and structural to identify how the areas of the associated with executive control and attention tend to have less activity in people who cannot be put into a hypnotic trance.

"There's never been a brain signature of being hypnotized, and we're on the verge of identifying one," said David Spiegel, MD, the paper's senior author and a professor of psychiatry and behavioral sciences. Such an advance would enable scientists to understand better the mechanisms underlying hypnosis and how it can be used more widely and effectively in clinical settings, added Spiegel, who also directs the Stanford Center for Integrative Medicine.

Spiegel estimates that one-quarter of the patients he sees cannot be hypnotized, though a person's hypnotizability is not linked with any specific . "There's got to be something going on in the brain," he said.

Hypnosis is described as a trance-like state during which a person has a heightened focus and concentration. It has been shown to help with brain control over sensation and behavior, and has been used clinically to help patients manage pain, control stress and anxiety and combat phobias.

Hypnosis works by modulating activity in associated with focused attention, and this study offers compelling new details regarding neural capacity for hypnosis.

"Our results provide novel evidence that altered in [the ] and [the dorsal ] may underlie hypnotizability," the researchers wrote in their paper.

For the study, Spiegel and his Stanford colleagues performed functional and structural of the brains of 12 adults with high hypnotizability and 12 adults with low hypnotizability.

The researchers looked at the activity of three different networks in the brain: the default-mode network, used when one's brain is idle; the executive-control network, which is involved in making decisions; and the salience network, which is involved in deciding something is more important than something else.

The findings, Spiegel said, were clear: Both groups had an active default-mode network, but highly hypnotizable participants showed greater co-activation between components of the executive-control network and the salience network. More specifically, in the brains of the highly hypnotizable group the left dorsolateral prefrontal cortex, an executive-control region of the brain, appeared to be activated in tandem with the dorsal anterior cingulate cortex, which is part of the salience network and plays a role in focusing of attention. By contrast, there was little functional connectivity between these two areas of the brain in those with low hypnotizability.

Spiegel said he was pleased that he and his team found something so clear. "The brain is complicated, people are complicated, and it was surprising we were able to get such a clear signature," he explained.

Spiegel also said the work confirms that hypnotizability is less about personality variables and more about cognitive style. "Here we're seeing a neural trait," he said.

The authors' next step is to further explore how these functional networks change during hypnosis. Spiegel and his team have recruited high- and low-hypnotizable patients for another study during which fMRI assessment will be done during hypnotic states. Funding for that work is being provided by the National Center for Complementary and Alternative Medicine.

Journal reference: JAMA Psychiatry search and more info website

Provided by Stanford University Medical Center search and more info website

4.6 /5 (5 votes)  

Rank 4.6 /5 (5 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Neuroscience created 10 hours ago | popularity 5 / 5 (4) | comments 0 | with audio podcast

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Neuroscience created 13 hours ago | popularity 4.9 / 5 (11) | comments 0 | with audio podcast report

Waiting for a sign? Researchers find potential brain 'switch' for new behavior

You're standing near an airport luggage carousel and your bag emerges on the conveyor belt, prompting you to spring into action. How does your brain make the shift from passively waiting to taking action when ...

Neuroscience created 14 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Neuroscience created 15 hours ago | popularity 4.2 / 5 (5) | comments 0 | with audio podcast report

Study shows where scene context happens in our brain

In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...

Neuroscience created 17 hours ago | popularity 4 / 5 (1) | comments 0 | with audio podcast


Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

Enrichment therapy effective among children with autism, study finds

Children with autism showed significant improvement after six months of simple sensory exercises at home using everyday items such as scents, spoons and sponges, according to UC Irvine neurobiologists.

Study finds vitamin C can kill drug-resistant TB (w/ video)

In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...